A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway-Reference-Cited by-同舟云学术

A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway

Published:2024-08-13 Issue:9 Volume:7 Page:2799-2819
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Froney Merrill M.¹,Cook Christian R.¹,Cadiz Alyssa M.¹,Flinter Katherine A.¹,Ledeboer Sara T.¹,Chan Bianca¹,Burris Lauren E.¹,Hardy Brian P.²,Pearce Kenneth H.²^ORCID,Wardell Alexis C.³,Golitz Brian T.⁴,Jarstfer Michael B.¹,Pattenden Samantha G.¹^ORCID

Affiliation:

1. UNC Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

2. UNC Eshelman School of Pharmacy, Center for Integrative Chemical Biology and Medicinal Chemistry, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. UNC Lineberger Comprehensive Cancer Center, Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. UNC Lineberger Comprehensive Cancer Center, Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

National Cancer Institute

Amgen Foundation

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.4c00251

Reference106 articles.

1. Mammalian Telomeres End in a Large Duplex Loop

2. The telomere hypothesis of cellular aging

3. Identification of a specific telomere terminal transferase activity in tetrahymena extracts

4. Senescence as a mode of tumor suppression.

5. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies